Efficacy and Safety of Prescription Omega-3-Acid Ethyl Esters (P-OM3) for the Prevention of Recurrent Symptomatic Atrial Fibrillation (AF)

被引:0
|
作者
Kowey, Peter R. [1 ]
Reiffel, James A. [2 ]
Ellenbogen, Kenneth A. [3 ]
Naccarelli, Gerald V. [4 ]
Pratt, Craig M. [5 ]
机构
[1] Main Line Hlth Heart Cntr Lankenau Hosp, Wynnewood, PA USA
[2] Columbia Univ, Med Ctr, New York, NY USA
[3] Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA
[4] Penn State Univ, Coll Med, Hershey, PA USA
[5] Methodist DeBakey Heart & Vasc Cntr, Houston, TX USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2217 / 2218
页数:2
相关论文
共 50 条
  • [41] Prescription omega-3 fatty acids did not prevent recurrent, symptomatic, paroxysmal or persistent atrial ibrillation
    Olshansky, Brian
    [J]. ANNALS OF INTERNAL MEDICINE, 2011, 154 (10)
  • [42] Effects of omega-3 fatty acid supplementation on the risk of atrial fibrillation (AF) and micro-AF in the OMEMI trial
    Myhre, P.
    Berge, T.
    Kalstad, A.
    Tveit, S. H.
    Laake, K.
    Schmidt, E. B.
    Solheim, S.
    Arnesen, H.
    Seljeflot, I.
    Tveit, A.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 2433 - 2433
  • [43] Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3-acid ethyl esters with an Advanced Lipid Technologies™ (ALT®)-based formulation
    Lopez-Toledano, Miguel A.
    Thorsteinsson, Thorsteinn
    Daak, Ahmed A.
    Maki, Kevin C.
    Johns, Colleen
    Rabinowicz, Adrian L.
    Sancilio, Frederick D.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (02) : 394 - 405
  • [44] Omega-3-Acid Ethyl Esters to Treat Dyslipidemia in Patients with Hiv: A Multi-Center Randomized Placebo-Controlled Trial
    Metkus, Thomas
    Timpone, Joseph
    Leaf, David
    Goetz, Matthew
    Harris, William
    Brown, Todd
    [J]. CIRCULATION, 2012, 126 (21)
  • [45] Effects of prescription omega-3-acid ethyl ester vs olive oil on macro- and microvascular function in subjects with type 2 diabetes mellitus
    Nandrean, S.
    Stirban, A.
    Pop, A.
    Goetting, C.
    Tamler, R.
    Gawlowski, T.
    Stratmann, B.
    Tschoepe, D.
    [J]. DIABETOLOGIA, 2009, 52 : S479 - S479
  • [46] Prescription omega-3 acid ethyl esters plus simvastatin 20 and 80 mg: effects in mixed dyslipidemia
    Maki, Kevin C.
    Lubin, Barry C.
    Reeves, Matthew S.
    Dicklin, Mary R.
    Harris, William S.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2009, 3 (01) : 33 - 38
  • [47] Omega-3 Ethyl Esters and Atrial Fibrillation or Flutter in Patients With Coronary Artery Disease: Results From a Randomized Trial
    Asbeutah, Abdul Aziz
    Mirza, Hasan
    Waseem, Smaha
    Amangurbanova, Maral
    Welty, Francine K.
    [J]. CIRCULATION, 2020, 142
  • [48] RETROSPECTIVE CASE SERIES OF LIPID EFFECTS IN PATIENTS SWITCHED FROM EPA plus DHA (OMEGA-3-ACID ETHYL ESTERS) TO HIGH-PURITY EPA (ICOSAPENT ETHYL)
    Crandell, James
    Tartaglia, Christina
    Tartaglia, Joseph
    [J]. CLINICAL CARDIOLOGY, 2015, 38 : 11 - 12
  • [49] Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apotipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia
    Davidson, Michael H.
    Maki, Kevin C.
    Bays, Harold
    Carter, Roderick
    Ballantyne, Christie M.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2009, 3 (05) : 332 - 340
  • [50] Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation: Results of a Double-Blind Randomized Clinical Trial (FORWARD) (NCT00597220)
    Macchia, Alejandro
    Grancelli, Hugo
    Varini, Sergio
    Nul, Daniel
    Ferrante, Daniel
    Mariani, Javier
    Laffaye, Nicolas
    Badra, Raul
    Figal, Julio
    Ramos, Silvina
    Tognoni, Gianni
    Doval, Hernan
    [J]. CIRCULATION, 2012, 126 (23) : 2780 - 2781